Breast Carcinoma: Understanding Types, Receptors & Treatment

Breast Carcinoma — Understanding It From Zero --- First, Understand the Breast The breast is made of two main structures — ducts and lobules. Lobules are the small glands that produce milk Ducts are the tubes that carry milk from the lobules to the nipple These two meet at a junction called the terminal duct lobular unit — and this is where almost all breast cancers begin Think of it like a tree. The lobules are the leaves, the ducts are the branches, and the nipple is the trunk. Cancer starts at the point where a leaf meets a branch. --- What is Breast Cancer? Normal breast cells grow, do their job, and die in an orderly way. Breast cancer happens when cells in the ducts or lobules start growing out of control — they stop following the rules, multiply uncontrollably, and eventually invade surrounding tissue or spread to other organs. --- How Does Cancer Start? — The Receptors Here is the most important concept to understand before anything else. Breast cells have receptors — think of receptors as locks on the surface of a cell. Certain substances act as keys that fit into these locks and tell the cell what to do. Three receptors matter most in breast cancer: 1. Estrogen Receptor (ER) Estrogen is the female hormone If a cancer cell has the ER lock, estrogen can stimulate it to grow We call this cancer ER positive ER positive cancers can be treated by blocking estrogen — this is why tamoxifen works 2. Progesterone Receptor (PR) Similar idea — progesterone stimulates growth if the receptor is present Almost always goes together with ER 3. HER2 (Human Epidermal growth factor Receptor 2) HER2 is a protein that tells cells to grow and divide Normally, cells have a small amount of HER2 In some cancers, the HER2 gene is amplified — meaning too many copies are made — so the cell has way too much HER2 on its surface This makes the cancer grow very fast We call this HER2 positive The good news: we have a drug called trastuzumab (Herceptin) that specifically targets HER2 Now, based on whether these three receptors are present or absent, breast cancers fall into three groups: --- The Three Types of Breast Cancer Type 1 — Luminal (ER positive, HER2 negative) The word "luminal" just means the cancer cells look and behave like the normal cells that line the inside of the ducts and lobules — the lumen. These are the most well-behaved cancer cells. ER is present → estrogen feeds this cancer HER2 is absent → not driven by HER2 Grows slowly Responds well to hormone-blocking drugs like tamoxifen Spreads mostly to bone Best prognosis of all three types Most common — about 50–65% of all breast cancers Type 2 — HER2 Positive Too much HER2 protein on the cancer cell surface This makes the cancer divide very fast More aggressive than luminal Can be ER positive or ER negative Spreads to bone, organs, and brain Treated with trastuzumab which blocks HER2 About 20% of breast cancers Type 3 — Triple Negative (TNBC) Triple negative simply means the cancer has none of the three receptors — no ER, no PR, no HER2. It is triple negative because all three tests come back negative. This matters a lot because: ER negative → tamoxifen won't work HER2 negative → trastuzumab won't work No targeted therapy exists — the only option is chemotherapy It is the most aggressive type Grows fast, spreads fast, relapses early Most common in young women, women of African descent, and women with BRCA1 gene mutations --- How Each Type Develops — The Three Pathways Think of each type having its own road from normal cell to cancer. Road 1 — Luminal Cancer Normal breast cell → acquires small mutations (especially in a gene called PIK3CA) → cells start looking slightly abnormal but are still inside the duct → this stage is called flat epithelial atypia → cells become more abnormal → atypical ductal hyperplasia (ADH) — abnormal cells are now multiplying more than normal but still contained → DCIS (cancer cells fully inside the duct, not yet broken out) → finally breaks through the duct wall → invasive luminal cancer Road 2 — TNBC Normal breast cell → BRCA1 gene is mutated (inherited or acquired) → TP53 gene also mutates → cells develop a p53 signature (early warning sign, hard to see under microscope) → DCIS → breaks out → invasive TNBC Road 3 — HER2 Cancer Normal breast cell → HER2 gene gets amplified (too many copies made) → cells grow fast → DCIS → breaks out → HER2 positive invasive cancer Note: No clear precursor lesion has been identified for HER2 cancer before the DCIS stage. --- Before It Breaks Out — Carcinoma In Situ "In situ" is Latin for "in its original place." This means the cancer cells are still trapped inside the duct or lobule. They cannot spread to other organs because they have no access to blood vessels or lymphatics yet. Think of it like a fire inside a sealed room. It is dangerous but contained. DCIS — Ductal Carcinoma In Situ Cancer cells inside the ducts, not yet broken through the wall Found almost always on mammogram — the cells die in th